Phathom Pharmaceuticals (PHAT) PT Raised to $20 at Guggenheim
Tweet Send to a Friend
(Updated - October 30, 2025 12:03 PM EDT)
Guggenheim analyst Yatin Suneja raised the price target on Phathom Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Yatin Suneja raised the price target on Phathom Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
